News

Walk On Project” funds an IDIBELL project with almost 100,000 euros

The Walk on Project (WOP) nonprofit foundation, in collaboration with BBK Fundazioa, will fund with 98,000 euros a research project led by Dr. Aurora Pujol, ICREA research professor in Bellvitge Institute for Biomedical Research (IDIBELL), who is an expert in Human Genetics and Neurodegenerative Diseases. The project, entitled “Pharmacological strategies for the regeneration of myelin […]

Leer más about Walk On Project” funds an IDIBELL project with almost 100,000 euros

Alfredo García, new Director of Bellvitge Hospital

Dr. Alfredo Garcia Diaz has been appointed managing director of the Bellvitge University Hospital and managing director of the South Metropolitan Territorial Management of the Catalan Institute of Health. Replaced in this role Dr. Xavier Corbella, who has been appointed manager of the Hospital Santa Creu i Sant Pau in Barcelona.

Leer más about Alfredo García, new Director of Bellvitge Hospital

Study of 14-3-3 proteins in chemotherapy resistance

Certain proteins, such as 14-3-3, conserve their basic functions of cell cycle control in diverse organisms, from worms to humans. In a study led by Julián Cerón and Simó Schwartz Jr, researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Research Institute of Vall d’Hebron (VHIR) respectively, have described germ line functions of par-5, […]

Leer más about Study of 14-3-3 proteins in chemotherapy resistance

IDIBELL project, funded by EMBO

Dr. Antonio Gentilella has get an EMBO Long-Term Fellowship The project, leaded by Dr. Antonio Gentilella and funded by an EMBO Long-Term Fellowship, is focussed on understanding the mechanisms by which the tumor suppressor p53, also known as the guardian of genome, is activated in response to ribosomal impairment, a cause of two rare anemias, […]

Leer más about IDIBELL project, funded by EMBO

Identified an anti-oncogene into an oncogene

A study led by Manel Esteller has discovered the existence of an antitumor molecule that has been originated within an oncogene. A common point in all human tumors is that they produce an activation of oncogenes, genes that cause cancer and they also cause a loss of function of the protective genes, called anti-oncogenes or […]

Leer más about Identified an anti-oncogene into an oncogene

World No Snuff

25% of IDIBELL staff is smoker May 31 is the World without Snuff. The Smoke-Free IDIBELL program is aimed at workers ready to quit smoking. It is a free personalized program offered by the Tobacco Control Unit of the ICO. To qualify for the Smoke-Free program IDIBELL, the smoker must be motivated to quit. According […]

Leer más about World No Snuff

First epigenome in Europe completed

A study led by Manel Esteller compares the epigenetic marks of a healthy person with a patient with a genetic disease Methylation Article’s reference:

Leer más about First epigenome in Europe completed

Identify genetic markers to predict male fertility

The diagnosis of male fertility is usually performed through the observation of the sperm in the microscope. However, a normal quality semen does not guarantee an adequate fertility. In fact, there is a considerable proportion of cases of unexplained infertility and data suggest that abnormal sperm function may have a genetic or molecular origin. A […]

Leer más about Identify genetic markers to predict male fertility

Discovered a new checkpoint of cell cycle control through joint action of two proteins

Alterations in the formation of ribosomes (the elements of the cell where proteins are made) cause the induction of p53 protein and cell cycle disruption. This process is crucial to understand fundamental biological processes and the emergence of various diseases. Now, scientists at the Bellvitge Biomedical Research Institute (IDIBELL) have found that this response is […]

Leer más about Discovered a new checkpoint of cell cycle control through joint action of two proteins
Scroll to Top